Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Cytyc, Digene Merger Offer Extended

SAN FRANCISCO, May 9 - Sample preparation firm Cytyc today extended its offer to purchase genomics diagnostics company Digene to May 23, eastern standard time.


The stock and cash deal, valued at $77 million, was set to expire today.


Under the terms of the merger agreement, Cytyc can extend the offer period if any of the conditions of the offer have not been met or waived, according to the companies.


As of the close of business on May 8, approximately 10.4 million shares of Digene common stock, representing about 58 percent of the total outstanding shares of the company, had been tendered and not withdrawn pursuant to the offer, according to Cytyc.


Both Cytyc, of Boxborough, Mass., and Gaithersburg, MD.-based Digene develop diagnostics related to cervical cancer: Cytyc is working on an automated system for pap testing, and Digene's test detects human papilloma virus, which is linked to cervical cancer.

The Scan

Latent HIV Found in White Blood Cells of Individuals on Long-Term Treatments

Researchers in Nature Microbiology find HIV genetic material in monocyte white blood cells and in macrophages that differentiated from them in individuals on HIV-suppressive treatment.

Seagull Microbiome Altered by Microplastic Exposure

The overall diversity and the composition at gut microbiome sites appear to coincide with microplastic exposure and ingestion in two wild bird species, according to a new Nature Ecology and Evolution study.

Study Traces Bladder Cancer Risk Contributors in Organ Transplant Recipients

In eLife, genome and transcriptome sequencing reveal mutation signatures, recurrent somatic mutations, and risky virus sequences in bladder cancers occurring in transplant recipients.

Genes Linked to White-Tailed Jackrabbits' Winter Coat Color Change

Climate change, the researchers noted in Science, may lead to camouflage mismatch and increase predation of white-tailed jackrabbits.